Development and Validation of Stability indicating HPLC Method for Determination of Nirogacestat in Bulk and Pharmaceutical Dosage Form

Authors

  • P. Ravi Sankar , M. Divya , J. Chanti Babu , SK. Reshma , T. Praveen kumar , D.V.S. Sarath Chandra , P. Srinivasa Babu Author

DOI:

https://doi.org/10.48047/z2mej921

Keywords:

HPLC, Nirogacestat, Degradation studies, ICH Guidelines.

Abstract

A simple, rapid, precise, sensitive and reproducible reverse phase high performance liquid chromatography
(HPLC) method has been developed for the quantitative analysis of Nirogacestat in pharmaceutical dosage
form. Chromatographic separation of Nirogacestat was achieved on Waters alliance e-2695 HPLC, by using
Symmetry shield RP-18 (150 x 4.6 mm, 3.5 µ) column and the mobile phase containing 1.15 gms ammonium
acetate is dissolved in 1lt of HPLC water pH-3.0/OPA & ACN in the ratio of 70:30 % v/v. The flow rate was 1.0
mL/min; detection was carried out by absorption at 269 nm using a photodiode array detector at ambient
temperature. The number of theoretical plates and tailing factor for Nirogacestat were NLT 2000 and should
not more than 2 respectively. % Relative standard deviation of peak areas of all measurements always less
than 2.0. 

Downloads

Download data is not yet available.

Downloads

Published

2025-02-20

How to Cite

Development and Validation of Stability indicating HPLC Method for Determination of Nirogacestat in Bulk and Pharmaceutical Dosage Form (P. Ravi Sankar , M. Divya , J. Chanti Babu , SK. Reshma , T. Praveen kumar , D.V.S. Sarath Chandra , P. Srinivasa Babu , Trans.). (2025). Cuestiones De Fisioterapia, 54(4), 1767-1783. https://doi.org/10.48047/z2mej921